DrugPatentWatch Database Preview
AMPICILLIN SODIUM Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Ampicillin Sodium patents expire, and when can generic versions of Ampicillin Sodium launch?
Ampicillin Sodium is a drug marketed by Acs Dobfar Spa, Antibiotice, Apothecon, Aurobindo Pharma, Consolidated Pharm, Hanford Gc, Hospira Inc, Intl Medication, Istituto Bio Ita Spa, Lilly, Mylan Labs Ltd, Sagent Pharms Inc, Sandoz, Watson Labs Inc, and West-ward Pharms Int. and is included in twenty-five NDAs.
The generic ingredient in AMPICILLIN SODIUM is ampicillin sodium. There are seventy drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
US ANDA Litigation and Generic Entry Outlook for Ampicillin Sodium
A generic version of AMPICILLIN SODIUM was approved as ampicillin sodium by SANDOZ on February 19th, 1987.
Summary for AMPICILLIN SODIUM
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 25 |
| Suppliers / Packagers: | 15 |
| Bulk Api Vendors: | 48 |
| Clinical Trials: | 8 |
| Patent Applications: | 867 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | AMPICILLIN SODIUM at DailyMed |
Recent Clinical Trials for AMPICILLIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| DongGuk University | N/A |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for AMPICILLIN SODIUM
| Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for AMPICILLIN SODIUM
US Patents and Regulatory Information for AMPICILLIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062816-003 | Oct 24, 1988 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Istituto Bio Ita Spa | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062719-002 | May 12, 1987 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hanford Gc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062772-007 | Apr 15, 1993 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lilly | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 062565-001 | Apr 4, 1985 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
